Green Banana Peel Extract for Stasis Dermatitis Treatment

Status Completed

Clinical Trial Summary

To develop and evaluate a pharmaceutical formula based on green banana peel extract for the treatment of stasis dermatitis.

Clinical Trial Description

Objective: to develop and evaluate a pharmaceutical formula based on green banana peel extract for the treatment of stasis dermatitis. Methods: it will be a clinical, interventional, longitudinal study, random sampling, Sample will have 20 patients divided into two groups. In the Control Group, a moisturizing cream with SPF 30 sunscreen plus a pharmaceutical formulation without green banana peel extract will be used, and in the Study Group, in addition to the SPF 30 sunscreen, a pharmaceutical formulation containing green banana peel extract will be used. Patients will undergo treatment for 90 days, applying the formulation twice a day, evaluated every 45 days through clinical, photographic and Chromatic Palette evaluation. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06427733
Study type	Interventional
Source	Universidade do Vale do Sapucai
Contact
Status	Completed
Phase	Phase 1
Start date	February 2, 2024
Completion date	May 15, 2024

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT04091087` - Study Evaluating Efficacy and Safety of Crisaborole in Adults With Stasis Dermatitis	Phase 2
	Completed	`NCT03022786` - Improving Value of Care for Patients With Severe Stasis Dermatitis	N/A